Yuan Lin, Ma Liying, Fan Xiujuan, Feng Yi, Peng Hong, Zhao Quanbi, Ruan Yuhua, Levy J A, Shao Yiming
State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Curr HIV Res. 2009 Jul;7(4):437-40. doi: 10.2174/157016209788680561.
Most of the HIV-infected long term survivors show strong CD8+ cell noncytotoxic antiviral response (CNAR) that plays as an important factor for maintaining the relative healthy state of infected individuals. HIV infected former blood donors (FBDs) in Anhui, China are the unique population that considered infected by the same or a related HIV strain by the same exposure route, and is better to be studied for viral and host immunological factors associated with disease progression, such as CNAR. We examined CNAR in 63 asymptomatic untreated HIV infected FBDs with different CD4+ cell counts and plasma viral loads. The average CD8+ : CD4+ cell ratio to reach 90% suppression of HIV replication in the groups with CD4+ cell counts of >500, 300-500 and <300 cells/microl were 0.85 : 1, 1.47 : 1 and 1.88 : 1 respectively (P<0.0001). The average CD8+ : CD4+ cell ratio to reach 90% suppression of HIV replication was 1.07 : 1 and 1.66 : 1 in the group with plasma viral load of <30,000 and >30,000 RNA copy/ml respectively (P=0.0002). The results indicated that CNAR activity in long-term HIV-1 infected FBDs correlates directly with CD4+ cell counts, and correlates reversely with plasma viral loads. Our findings in long term infected FBDs confirm the clinical relevancy of CNAR and suggest that CNAR could be an additional marker to help determine the optimal time for starting therapy in HIV infected person.
大多数长期存活的HIV感染者表现出强烈的CD8 +细胞非细胞毒性抗病毒反应(CNAR),这是维持感染者相对健康状态的重要因素。中国安徽的HIV感染前献血者(FBDs)是独特的群体,他们被认为通过相同的暴露途径感染了相同或相关的HIV毒株,对于研究与疾病进展相关的病毒和宿主免疫因素(如CNAR)而言是更理想的研究对象。我们检测了63名未经治疗的无症状HIV感染FBDs的CNAR,这些患者具有不同的CD4 +细胞计数和血浆病毒载量。CD4 +细胞计数>500、300 - 500和<300个细胞/微升的组中,HIV复制达到90%抑制时的平均CD8 +:CD4 +细胞比值分别为0.85:1、1.47:1和1.88:1(P<0.0001)。血浆病毒载量<30,000和>30,000 RNA拷贝/毫升的组中,HIV复制达到90%抑制时的平均CD8 +:CD4 +细胞比值分别为1.07:1和1.66:1(P = 0.0002)。结果表明,长期HIV-1感染FBDs中的CNAR活性与CD4 +细胞计数直接相关,与血浆病毒载量呈负相关。我们在长期感染FBDs中的发现证实了CNAR的临床相关性,并表明CNAR可能是有助于确定HIV感染者开始治疗最佳时机的另一个标志物。